T21.3 Kilder

Larkin PJ et al. Ann Oncol. 2018 Oct 1;29 (Supplement_4): iv111-iv125. Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. ESMO Guidelines Committee. PMID: 30016389 DOI: 10.1093/annonc/mdy148

Ræder J. et al. Fra Ketobemidon til morfin eller oksykodon, Tidsskr Nor Legeforen 2016; : 1518-9. doi:10.4045/ Tidsskr: 16.0510

Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M,Ripamonti CI, ESMO Guidelines Committee. (2018). Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Annals of Oncology, 29(Supplement_4), iv166-iv191. 

Twycross R, Wilcock A, Howard P. (2014). Palliative care formulary,.5th edition. Palliativedrugs.co 

Fredheim O M S, Husby K M, Kaasa S, Borchgrevink P C, Klepstad P. (2006). LEDERE-Aktuelt-Legemidler i praksis-Opioidrotasjon og metadon i smertebehandling. Tidsskrift for den Norske laegeforening, 126(17), 2272-2274. 

Mercadante S, & Caraceni A. (2011). Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliative Medicine, 25(5), 504-515. 

Bush SH, Lawlor PG, Ryan K et al, on behalf of the ESMO Guidelines Committee (2018) Annals of Oncology, 29 (Supplement_4), iv143-iv165.